University Hospital Mannheim, Department of Surgery
Welcome,         Profile    Billing    Logout  
 3 Trials 
5 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Ronellenfitsch, Ulrich
TATRA, NCT06414031: Tranexamic Acid for Reduction of Transfusion in Abdominal Surgery

Recruiting
3
850
Europe
Tranexamic Acid, Tranexamsäure Carinopharm 100mg/ml, Placebo, Isotone Kochsalz-Lösung 0,9% Infusionslösung
Ulrich Ronellenfitsch, MD, German Federal Ministry of Education and Research, Coordinating Centre for Clinical Trials Halle
Surgical Blood Loss, Transfusion-dependent Anemia, Abdomen Disease
11/25
11/25
NCT04246684: Short RT Versus RCT,Followed by Chemo.and Organ Preservation for Interm and High-risk Rectal Cancer Patients

Active, not recruiting
3
702
Europe
Oxaliplatin, 85 mg/m2, Control arm, 5FU; 2400 mg/m2, 5-FU, control arm, 5FU, 250 mg/m2, Experimental arm: 5-FU, 5FU, 2400 mg/m2, experimental arm, Oxaliplatin 50 mg/m2, Experimental arm, Folinic Acid, 400 mg/m2, Folinic Acid, Radiotherapy control, 5x5 Gy: 25 Gy, Capecitabine, 1000 mg/m2, Capecitabine, Oxaliplatin 85 mg/m2, radiotherapy experimental, 30 x 1,8 Gy: 54 Gy, Capecitabine, 825 mg/m2, Oxaliplatin, 130 mg/m2, Oxaliplatin
Prof. Dr. med. Claus Rödel
Rectal Cancer Stage III
09/23
09/28
PRESTO, NCT05713838: Organ Preservation With Durvalumab-based Immunotherapy in Combination With Chemoradiation as Definitive Therapy for Early Stage Esophageal Adenocarcinoma With Indication for Radical Surgery

Recruiting
2
32
Europe
Durvalumab, IMFINZI, FLOT, mFOLFOX-6, Radiotherapy
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Esophagus Adenocarcinoma
12/25
12/28
HOLIPANC, NCT04617457 / 2019-002734-37: Chemotherapy and Surgical Resection in Patients With Hepatic Oligometastatic Adenocarcinoma of the Pancreas

Recruiting
2
150
Europe
nal-irinotecan (nal-iri) (Onyvide), oxaliplatin (ox), 5-fluouracil (5-FU), folinic acid (FA), nal-irinotecan (nal-iri), oxaliplatin (ox), 5-fluouracil (5-FU), folinic acid (FA), ONIVYDE TM
University of Cologne, Servier
Pancreatic Cancer, Metastasis, Surgery, Oligometastatic Disease
12/24
09/25
PREVADER, NCT04136769: Preoperative/Neoadjuvant Therapy and Vascular Debranching Followed by Resection for Locally Advanced Pancreatic Cancer

Terminated
N/A
3
Europe
Visceral Debranching, Revascularisation of visceral arteries
Ulrich Ronellenfitsch, MD
Pancreas Cancer
12/24
12/24

Download Options